207 related articles for article (PubMed ID: 9672345)
1. p53 and bcl-2 protein expression in rectosigmoid adenomas.
Papatheodoridis GV; Kapranos N; Tzouvala M; Triantafyllou K; Elemenoglou I; Karamanolis DG
Am J Gastroenterol; 1998 Jul; 93(7):1136-40. PubMed ID: 9672345
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of rectosigmoid adenomas as predictors of synchronous advanced proximal colon neoplasms.
Papatheodoridis GV; Triantafyllou K; Tzouvala M; Paspatis G; Xourgias V; Karamanolis DG
Am J Gastroenterol; 1996 Sep; 91(9):1809-13. PubMed ID: 8792703
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of morphologic characteristics in rectosigmoid adenomatous polyps for the probability of synchronous polyps or cancer in the proximal colon.
Erdem L; Akbayir N; Yildirim S; Köksal HM; Yenice N; Gültekin OS; Sakiz D; Peker O
Turk J Gastroenterol; 2005 Dec; 16(4):207-11. PubMed ID: 16547849
[TBL] [Abstract][Full Text] [Related]
4. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
Sundblad AS; Chumbita RL; Zoppi JA
Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
[TBL] [Abstract][Full Text] [Related]
5. [Expression of protein p53 in the adenoma-colorectal carcinoma sequence].
Gafà R; Lanza G
Pathologica; 1998 Aug; 90(4):351-6. PubMed ID: 9793394
[TBL] [Abstract][Full Text] [Related]
6. Predictors of the early development of advanced metachronous colon adenomas.
Triantafyllou K; Papatheodoridis GV; Paspatis GA; Vasilakaki TH; Elemenoglou I; Karamanolis DG
Hepatogastroenterology; 1997; 44(14):533-8. PubMed ID: 9164533
[TBL] [Abstract][Full Text] [Related]
7. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas.
Atkin WS; Morson BC; Cuzick J
N Engl J Med; 1992 Mar; 326(10):658-62. PubMed ID: 1736104
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
10. Rectosigmoid polyps as markers of proximal colonic neoplasms: a cost benefit analysis of different diagnostic protocols.
Arrigoni A; Pennazio M; Rossini FP
Anticancer Res; 1995; 15(2):563-7. PubMed ID: 7763038
[TBL] [Abstract][Full Text] [Related]
11. Adenomas of the colon: overexpression of p53 protein and risk factors.
Speroni AH; Vanzulli SI; Meiss RP
Endoscopy; 1998 Sep; 30(7):623-6. PubMed ID: 9826142
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
Darmon E; Cleary KR; Wargovich MJ
Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.
Campo E; de la Calle-Martin O; Miquel R; Palacin A; Romero M; Fabregat V; Vives J; Cardesa A; Yague J
Cancer Res; 1991 Aug; 51(16):4436-42. PubMed ID: 1868464
[TBL] [Abstract][Full Text] [Related]
14. Cell turnover of serrated adenomas.
Ladas SD; Kitsanta P; Triantafyllou K; Tzathas C; Spiliadi C; Raptis SA
J Pathol; 2005 May; 206(1):62-7. PubMed ID: 15751053
[TBL] [Abstract][Full Text] [Related]
15. Influence of the c-erb B-2, nm23, bcl-2 and p53 protein markers on colorectal cancer.
Demirbaş S; Sücüllü I; Yildirim S; Celenk T
Turk J Gastroenterol; 2006 Mar; 17(1):13-9. PubMed ID: 16830272
[TBL] [Abstract][Full Text] [Related]
16. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study.
Mueller J; Mueller E; Hoepner I; Jütting J; Bethke B; Stolte M; Höfler H
J Pathol; 1996 Nov; 180(3):259-65. PubMed ID: 8958802
[TBL] [Abstract][Full Text] [Related]
17. Do distal adenomas mandate total colonoscopy?
Khan A; Shrier I; Gordon PH
Surg Endosc; 2003 Jun; 17(6):886-90. PubMed ID: 12658426
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of diminutive colonic adenoma trial: the PREDICT trial.
Schoenfeld P; Shad J; Ormseth E; Coyle W; Cash B; Butler J; Schindler W; Kikendall WJ; Furlong C; Sobin LH; Hobbs CM; Cruess D; Rex D;
Clin Gastroenterol Hepatol; 2003 May; 1(3):195-201. PubMed ID: 15017491
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
